Oracle Corporation is rated a Buy due to robust execution, margin inflection, and high potential cloud growth opportunity.

Oracle loses executives health division as several senior leaders depart its health records unit following the Cerner acquisition.

Oracle is actively promoting its AI data center progress and job creation efforts amidst significant investor concerns. The company's massive $300 billion OpenAI cloud contract, signed in September ...

The likelihood that Nvidia NVDA0.66%increase; green up pointing triangle will be investing far less than $100 billion in OpenAI raises big questions for Oracle ORCL-1.50%decrease; red down pointing ...

Forbes contributors publish independent expert analyses and insights. I consult on marketing strategy, content creation, and messaging. Oracle burned through $10 billion in cash in its most recent ...

NEW YORK, Jan 14 (Reuters) - Oracle (ORCL.N), opens new tab was sued on Wednesday by bondholders who say they suffered losses because the company ‌chaired by billionaire Larry Ellison failed to ...

Larry Ellison’s Oracle is stumbling into the end of the year with its shares taking a beating. The tech firm’s stock has plummeted 30% so far this quarter, CNBC noted Friday. Only four trading days ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Oracle’s stock fell more than 12% on Thursday on growing fears about the software giant’s massive AI spending — shaving more than $30 billion off co-founder Larry Ellison’s fortune. The Texas-based ...

Kara Greenberg is a senior news editor for Investopedia, where she does work writing, editing, and assigning daily markets and investing news. Prior to joining Investopedia, Kara was a researcher and ...

The clinical-stage biotech might have a successful drug on its hands, if a relatively early-stage clinical trial is any indication. Its REC-4881 did very well in the testing. 10 stocks we like better ...